{"database": "openregs", "table": "dockets", "rows": [["FDA-2026-P-3632", "FDA", "Requests that the FDA to determine that PRALIDOXIME CHLORIDE (AUTOINJECTOR) 600 mg/2 mL intramuscular solution, (NDA 018986) from Meridian Medical Technologies Inc. was not discontinued or withdrawn due to safety or efficacy reasons.", "Nonrulemaking", "2026-04-02T21:19:55Z", "0b000064b924c546", null, null, null, null, "[\"CDER\", \"Citizen Petition\", \"Premier Research International LLC\", \"to determine that\", \"PRALIDOXIME CHLORIDE AUTOINJECTOR\", \"600 mg 2 mL intramuscular solution\", \"NDA 018986\", \"from Meridian Medical Technologies Inc\", \"was not discontinued or\", \"withdrawn due to safety or efficacy reasons\", \"OPEN\"]", "CDER", "Requests that the FDA to determine that PRALIDOXIME CHLORIDE (AUTOINJECTOR) 600 mg/2 mL intramuscular solution, (NDA 018986) from Meridian Medical Technologies Inc. was not discontinued.", null, null, "{\"displayProperties\": [{\"name\": \"generic\", \"label\": \"Docket Item Code\", \"tooltip\": \"An agency specific code that identifies the type of document that established the docket (regulatory action).\"}, {\"name\": \"program\", \"label\": \"Center\", \"tooltip\": \"The agency specific program associated with the docket (regulatory action); equivalents: Docket Item Code,  Location.\"}, {\"name\": \"field2\", \"label\": \"Docket Status\", \"tooltip\": \"Used to Identity that a Docket's Status is Open or Closed\"}, {\"name\": \"shortTitle\", \"label\": \"Short Title\", \"tooltip\": \"A combination of letters and or numbers assigned to an agency's regulatory action for purposes of brevity.\"}], \"keywords\": [\"CDER\", \"Citizen Petition\", \"Premier Research International LLC\", \"to determine that\", \"PRALIDOXIME CHLORIDE AUTOINJECTOR\", \"600 mg 2 mL intramuscular solution\", \"NDA 018986\", \"from Meridian Medical Technologies Inc\", \"was not discontinued or\", \"withdrawn due to safety or efficacy reasons\", \"OPEN\"], \"modifyDate\": \"2026-04-02T21:19:55Z\", \"dkAbstract\": null, \"agencyId\": \"FDA\", \"program\": \"CDER\", \"shortTitle\": \"Requests that the FDA to determine that PRALIDOXIME CHLORIDE (AUTOINJECTOR) 600 mg/2 mL intramuscular solution, (NDA 018986) from Meridian Medical Technologies Inc. was not discontinued.\", \"subType2\": null, \"title\": \"Requests that the FDA to determine that PRALIDOXIME CHLORIDE (AUTOINJECTOR) 600 mg/2 mL intramuscular solution, (NDA 018986) from Meridian Medical Technologies Inc. was not discontinued or withdrawn due to safety or efficacy reasons.\", \"generic\": \"P\", \"field1\": null, \"docketType\": \"Nonrulemaking\", \"petitionNbr\": null, \"rin\": null, \"organization\": null, \"legacyId\": null, \"subType\": null, \"category\": null, \"field2\": \"OPEN\", \"effectiveDate\": null, \"objectId\": \"0b000064b924c546\"}", "single_get"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id", "rin", "dkabstract", "category", "subtype", "keywords", "program", "short_title", "effective_date", "organization", "attrs_raw", "attr_source"], "primary_keys": ["id"], "primary_key_values": ["FDA-2026-P-3632"], "units": {}, "query_ms": 0.2046343870460987, "source": "U.S. government sources, plus a few identifier registries; each is listed on the methodology page", "source_url": "https://datadawn.org/methodology#data", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}